Cargando…

Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID‐19

A 69‐year‐old man with a history of type 2 diabetes and high blood pressure was diagnosed with coronavirus disease 2019 (COVID‐19). He had hyperferritinaemia and respiratory failure. Despite the initiation of favipiravir and high‐dose corticosteroid and ceftriaxone, his respiratory failure progresse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishiwari, Mayuko, Togashi, Yuki, Takoi, Hiroyuki, Kikuchi, Ryota, Kono, Yuta, Abe, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604553/ https://www.ncbi.nlm.nih.gov/pubmed/33163186 http://dx.doi.org/10.1002/rcr2.679

Ejemplares similares

Impact of sarcopenia on chemotherapy‐triggered exacerbation of interstitial lung disease in patients with non‐small cell lung cancer
por: Kikuchi, Ryota, et al.
Publicado: (2021)

Early intervention of plasma exchange combined with intensive immunosuppressive treatment for anti-MDA-5 antibody–positive rapidly progressive interstitial pneumonia: Two case reports
por: Ishiwari, Mayuko, et al.
Publicado: (2021)

Surfactant protein D: A useful biomarker for distinguishing COVID‐19 pneumonia from COVID‐19 pneumonia‐like diseases
por: Togashi, Yuki, et al.
Publicado: (2022)

Glasgow Prognostic Score predicts chemotherapy‐triggered acute exacerbation‐interstitial lung disease in patients with non‐small cell lung cancer
por: Kikuchi, Ryota, et al.
Publicado: (2021)

Glasgow prognostic score for prediction of chemotherapy‐triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer
por: Kikuchi, Ryota, et al.
Publicado: (2021)

The place of early haemoperfusion with polymyxin B fibre column in the treatment of sepsis
por: Ronco, Claudio
Publicado: (2005)

Modulation of inflammatory response related to severe peritonitis by polymyxin-B haemoperfusion
por: Coudroy, R, et al.
Publicado: (2015)

Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis
por: Fujii, Tomoko, et al.
Publicado: (2016)

Consensus Statement on the definition and classification of metabolic hyperferritinaemia
por: Valenti, Luca, et al.
Publicado: (2023)

Orbital apex syndrome associated with intraorbital metastasis of lung cancer
por: Ookuma, Takashi, et al.
Publicado: (2022)

Beneficial effect modification on survival outcome of sepsis between ART-123 and polymyxin B‑immobilised haemoperfusion: a nationwide Japanese registry study
por: Mochizuki, Katsunori, et al.
Publicado: (2020)

Double‐ring sign in granulocyte colony‐stimulating factor‐induced vasculitis
por: Mizushima, Reimi, et al.
Publicado: (2022)

Management of severe theophylline overdosage by charcoal haemoperfusion.
por: Uprichard, A. C., et al.
Publicado: (1984)

Recently published papers: A review of novel strategies in the prevention of hospital-acquired infections, the ability of intensivists to perform echocardiography, and the benefit of polymyxin B haemoperfusion in abdominal sepsis
por: Hayward, James, et al.
Publicado: (2009)

The effect of endotoxin adsorber haemoperfusion on microcirculation in septic pigs
por: Yeh, Y-C, et al.
Publicado: (2015)

Time-dependent haemoperfusion after acute paraquat poisoning
por: Wang, Hao-Ru, et al.
Publicado: (2017)

Favipiravir-induced fever in coronavirus disease 2019: A report of two cases
por: Takoi, Hiroyuki, et al.
Publicado: (2020)

Hyperferritinaemia in Dengue Virus Infected Patients Is Associated with Immune Activation and Coagulation Disturbances
por: van de Weg, Cornelia A. M., et al.
Publicado: (2014)

Hyperferritinaemia-cataract syndrome: Worldwide mutations and phenotype of an increasingly diagnosed genetic disorder
por: Millonig, Gunda, et al.
Publicado: (2010)

Haemoperfusion should only be used for COVID-19 in the context of randomized trials
por: Clark, Edward G., et al.
Publicado: (2020)

Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyperferritinaemia
por: Zhou, Lanlan, et al.
Publicado: (2022)

Treatment for severe COVID-19 with a biomimetic sorbent haemoperfusion device in patients on haemodialysis
por: Sandoval, Diego, et al.
Publicado: (2021)

The efficacy of haemoperfusion combined with continuous venovenous haemodiafiltration in the treatment of severe viral encephalitis in children
por: Zhao, Jun-Lin, et al.
Publicado: (2023)

The Value of Plasma Paraquat Concentration in Predicting Therapeutic Effects of Haemoperfusion in Patients with Acute Paraquat Poisoning
por: Shi, Yunying, et al.
Publicado: (2012)

Endotoxin‐induced changes in expression of cyclooxygenase isoforms in the lamellar tissue of extracorporeally haemoperfused equine limbs
por: Patan‐Zugaj, Bianca, et al.
Publicado: (2019)

Prolonged fever and hyperferritinaemia: a puzzling diagnosis of neonatal herpes simplex virus infection during COVID-19 pandemic
por: Badawy, Mohammed Kamal, et al.
Publicado: (2021)

Novel mutations in the ferritin-L iron-responsive element that only mildly impair IRP binding cause hereditary hyperferritinaemia cataract syndrome
por: Luscieti, Sara, et al.
Publicado: (2013)

Multimodality treatment in immunocompromised patients with severe COVID‐19: the role of IL‐6 inhibitor, intravenous immunoglobulin, and haemoperfusion
por: Leelayuwatanakul, Nophol, et al.
Publicado: (2021)

Case Report: Respiratory paralysis associated with polymyxin B therapy
por: Ning, Yachan, et al.
Publicado: (2022)

Respiratory arrest associated with polymyxin B in a lung transplant patient
por: Chen, Wen-Hui, et al.
Publicado: (2020)

The Difference Between Polymyxin B and Polymyxin E in Causing Skin Hyerpigmentation
por: Zou, Dongna, et al.
Publicado: (2021)

Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Column-direct Hemoperfusion
por: Kusaba, Yusaku, et al.
Publicado: (2020)

Fenofibrate inhibits TGF‐β‐induced myofibroblast differentiation and activation in human lung fibroblasts in vitro
por: Kikuchi, Ryota, et al.
Publicado: (2021)

Polymyxin B Etest Fails to Distinguish Carbapenem-resistant Enterobacteriaceae with Elevated Polymyxin B MICs
por: Kulengowski, Brandon, et al.
Publicado: (2017)

Polymyxin B complexation enhances the antimicrobial potential of graphene oxide
por: Pandit, Santosh, et al.
Publicado: (2023)

Functional characterization of a novel non-coding mutation “Ghent +49A > G” in the iron-responsive element of L-ferritin causing hereditary hyperferritinaemia-cataract syndrome
por: Van de Sompele, Stijn, et al.
Publicado: (2017)

Transcriptional responses of Burkholderia cenocepacia to polymyxin B in isogenic strains with diverse polymyxin B resistance phenotypes
por: Loutet, Slade A, et al.
Publicado: (2011)

2262. Ceftazidime–Avibactam vs. Polymyxin B in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
por: John, Jamie, et al.
Publicado: (2019)

Polymyxin B-Induced Skin Hyperpigmentation
por: Wen, Xueke, et al.
Publicado: (2020)

Resveratrol enhances the antimicrobial effect of polymyxin B on Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance
por: Liu, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_etol6qsjdqi6dupp7d7qu5q1dl